Habit Celebrates “Good Habits Day” with Free Double Charburgers to Support No Kid Hungry

Habit Celebrates “Good Habits Day” with Free Double Charburgers to Support No Kid Hungry Doing good never tasted so good. Join Habit on Nov 15 for Good Habits Day. GlobeNewswire November 12, 2025 IRVINE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Habit is celebrating its 56th birthday the best way it knows how: by giving […]

PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results

PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results GlobeNewswire November 12, 2025 Face-to-Face Pre-NDA Meeting with the FDA Scheduled for Early December; NDA Submission for D-PLEXâ‚₀₀ On Track for Early 2026 Advancements in Discussions with Potential U.S. Partners Following Positive Phase 3 Trial Results Company Continues to Advance Towards Commercial Manufacturing Readiness

BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates

BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates GlobeNewswire November 12, 2025 Positive FDA feedback confirms clear clinical pathway for BX011 targeting S. aureus in Diabetic Foot Infections, building on Company's prior Phase 2 success BiomX expects FDA feedback on BX004 clinical hold imminently; Enrollment and dosing of patients outside the U.S.

Verde Announces Q3 2025 Earnings Results

Verde Announces Q3 2025 Earnings Results GlobeNewswire November 12, 2025 SINGAPORE, Nov. 12, 2025 (GLOBE NEWSWIRE) — Verde AgriTech Ltd (TSX: NPK | OTCQX: VNPKF) (“Verde” or the “Company“) announces its operating and financial results for the period ended September 30, 2025 (“Q3 2025“). All figures are in Canadian dollars, unless stated otherwise. Average exchange

Purpose Investments Announces New Fund Name and New Investment Strategy for Purpose International Enhanced Equity Income Fund (formerly, Purpose International Tactical Hedged Equity Fund)

Purpose Investments Announces New Fund Name and New Investment Strategy for Purpose International Enhanced Equity Income Fund (formerly, Purpose International Tactical Hedged Equity Fund) The new fund strategy aims to provide investors with attractive monthly income while providing exposure to a diversified portfolio of international companies GlobeNewswire November 12, 2025 TORONTO, Nov. 12, 2025 (GLOBE

Toobit Launches ITE Trading Conquest Following Presale Sellout

GEORGE TOWN, Cayman Islands, Nov. 12, 2025 (GLOBE NEWSWIRE) — Toobit, the award-winning global cryptocurrency exchange, today announces the launch of the Idle Tribe Era (ITE) Trading Conquest, a two-part campaign with a prize pool of $8,000 and 1,250,000 ITE tokens. This campaign follows the success of the ITE presale on Toobit Launchpad, which sold

Bybit’s Lazarus Security Lab Reveals Hidden Fund-Freezing Functions Across 16 Major Blockchains

A new report byBybit's Lazarus Security Lab has revealed that 16 major blockchains include code that allows them to freeze or restrict user funds. https://mma.prnewswire.com/media/2821180/Image.jpg The report, titled “Blockchain Freezing Exposed: Examine The Impact of Fund Freezing Ability in Blockchain,” is the first large-scale analysis of how blockchains can intervene in user transactions to contain

Toobit Launches ITE Trading Conquest Following Presale Sellout

Toobit Launches ITE Trading Conquest Following Presale Sellout GlobeNewswire November 12, 2025 GEORGE TOWN, Cayman Islands, Nov. 12, 2025 (GLOBE NEWSWIRE) — Toobit, the award-winning global cryptocurrency exchange, today announces the launch of the Idle Tribe Era (ITE) Trading Conquest, a two-part campaign with a prize pool of $8,000 and 1,250,000 ITE tokens. This campaign

Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference

(ASX – Trade24:ATH.AX),(NASDAQ:ATHE), MELBOURNE, Australia and SAN FRANCISCO, Nov. 12, 2025 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer of Alterity, will deliver a corporate update at the Bell

Fluor Corporation (FLR) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of November 14, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / November 12, 2025 / If you suffered a loss on your Fluor Corporation (NYSE:FLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluor-corporation-lawsuit-submission-form?prid=176905&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Scroll to Top